What are the characteristics of rheumatic and immunological diseases?

Rheumatic and autoimmune diseases encompass a diverse group of disorders characterized by dysregulation of the immune system, leading to chronic inflammation and damage to connective tissues, joints, muscles, and sometimes internal organs. Key features include systemic involvement—many of these conditions (e.g., systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis) affect multiple organ systems beyond the musculoskeletal apparatus, such as skin, kidneys, lungs, heart, and nervous system. They often follow a relapsing-remitting course, with periods of active disease flares alternating with remission. Autoantibodies—such as rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, antinuclear antibodies (ANA), and anti-double-stranded DNA (anti-dsDNA)—are frequently detectable and serve both diagnostic and prognostic roles. Genetic predisposition (e.g., HLA-DR4 in rheumatoid arthritis, HLA-B27 in ankylosing spondylitis) interacts with environmental triggers—including infections, smoking, and ultraviolet light—to initiate and perpetuate disease. Histopathologically, affected tissues typically show lymphocytic infiltration, synovitis, vasculitis, or fibrosis depending on the specific condition. Early diagnosis and targeted immunomodulatory therapy—including conventional synthetic DMARDs (e.g., methotrexate), biologic agents (e.g., TNF inhibitors, B-cell depleters), and newer JAK inhibitors—are critical to preventing irreversible structural damage and preserving long-term function.